ACM
DCPH

Atika Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Atika Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-127,500
Closed -$7.62M – 128
2020
Q2 		$7.62M Sell
127,500
-13,500
-10% -$722K 0.98% 40
2020
Q1 		$5.8M Buy
+141,000
New +$7.83M 1.11% 30

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Atika Capital Management's DCPH Position: Q3 2020 in Review

Atika Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2020, closing a stake of 127,500 shares — an estimated $7.62M sold.

Atika Capital Management first reported a position in DCPH in Q1 2020 and held it in 2 quarters. The position peaked at $7.62M in Q2 2020. 161 funds tracked by Wall St. Rank hold DCPH as of Q3 2020.

  • Atika Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Atika Capital Management sold 127,500 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $7.62M.
  • Atika Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Atika Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $7.62M in Q2 2020.
  • 161 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on Atika Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.